Cover Picture
Phototherapy: Using Graphene Oxide High Near-Infrared Absorbance for Photothermal Treatment of Alzheimer's Disease (Adv. Mater. 13/2012)
Article first published online: 27 MAR 2012
DOI: 10.1002/adma.201290072
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Li, M., Yang, X., Ren, J., Qu, K. and Qu, X. (2012), Phototherapy: Using Graphene Oxide High Near-Infrared Absorbance for Photothermal Treatment of Alzheimer's Disease (Adv. Mater. 13/2012). Adv. Mater., 24: 1621. doi: 10.1002/adma.201290072
Publication History
- Issue published online: 27 MAR 2012
- Article first published online: 27 MAR 2012
- Abstract
- Cited By
Keywords:
- Alzheimer's disease;
- amyloid;
- graphene;
- nanomaterials;
- phototherapy

Inhibition of Aβ aggregation has shown promising against Alzheimer's disease in clinical trials. X. Qu and co-workers report a novel strategy on page 1722 which can dissociate amyloid aggregation using local heat generated by a clinically used amyloid-staining, dye-modified graphene oxide (GO) under NIR laser irradiation. With its high NIR absorbance, good biocompatibility, and its ability to cross the blood-brain barrier, the newly synthesized GO can efficiently dissociate Aβ fibrils, protect cells against Aβ-related toxicity, and be monitored in real time.

1521-4095/asset/olbannercenter.gif?v=1&s=529a7434a29cae1cc1d6c7ab89395d70e2677ce1)
